MedTrace Logo

Efficacy and Safety of DA-9401 on Improvement of Sperm Motility

NCT03258437 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2018-03-20

No results posted yet for this study

Summary

This study was conducted to investigate the effects of daily supplementation of Allium cepa L. and Cuscuta chinensis Lam. Extract Mixtures (DA-9401) on improvement of sperm motility.

Conditions

  • Spermatocele

Interventions

DIETARY_SUPPLEMENT

DA-9401

DIETARY_SUPPLEMENT

Placebo

Placebo for 12 weeks.

Sponsors & Collaborators

  • Korean Society for Sexual Medicine and Andrology

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-04-12
Primary Completion
2018-01-30
Completion
2018-01-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03258437 on ClinicalTrials.gov